Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 1
1961 3
1962 4
1963 4
1964 3
1965 4
1966 3
1967 5
1968 3
1969 7
1970 6
1971 2
1972 5
1973 2
1974 6
1976 2
1977 4
1978 4
1979 3
1980 5
1981 5
1982 7
1983 14
1984 9
1985 5
1986 6
1987 7
1988 11
1989 5
1990 4
1994 2
1995 2
1996 6
1997 3
1998 9
1999 6
2000 9
2001 10
2002 6
2003 6
2004 5
2005 9
2006 11
2007 8
2008 17
2009 13
2010 14
2011 23
2012 21
2013 25
2014 19
2015 16
2016 17
2017 23
2018 9
2019 20
2020 24
2021 32
2022 42
2023 20
2024 28
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

554 results

Results by year

Filters applied: . Clear all
Page 1
Current advances in pulmonary functional imaging.
Nakamura H, Hirai T, Kurosawa H, Hamada K, Matsunaga K, Shimizu K, Konno S, Muro S, Fukunaga K, Nakano Y, Kuwahira I, Hanaoka M. Nakamura H, et al. Among authors: hanaoka m. Respir Investig. 2024 Jan;62(1):49-65. doi: 10.1016/j.resinv.2023.09.004. Epub 2023 Nov 8. Respir Investig. 2024. PMID: 37948969 Free article. Review.
Lung imaging in COPD and asthma.
Tanabe N, Nakagawa H, Sakao S, Ohno Y, Shimizu K, Nakamura H, Hanaoka M, Nakano Y, Hirai T. Tanabe N, et al. Among authors: hanaoka m. Respir Investig. 2024 Nov;62(6):995-1005. doi: 10.1016/j.resinv.2024.08.014. Epub 2024 Aug 29. Respir Investig. 2024. PMID: 39213987 Free article. Review.
Anamorelin for cancer cachexia.
Nishie K, Sato S, Hanaoka M. Nishie K, et al. Among authors: hanaoka m. Drugs Today (Barc). 2022 Mar;58(3):97-104. doi: 10.1358/dot.2022.58.3.3381585. Drugs Today (Barc). 2022. PMID: 35274629 Review.
Update on the treatment of cancer cachexia.
Nishie K, Nishie T, Sato S, Hanaoka M. Nishie K, et al. Among authors: hanaoka m. Drug Discov Today. 2023 Sep;28(9):103689. doi: 10.1016/j.drudis.2023.103689. Epub 2023 Jun 28. Drug Discov Today. 2023. PMID: 37385369 Review.
Nationwide survey of refractory asthma with bronchiectasis by inflammatory subtypes.
Nomura N, Matsumoto H, Yokoyama A, Nishimura Y, Asano K, Niimi A, Tohda Y, Harada N, Nagase H, Nagata M, Inoue H, Kondo M, Horiguchi T, Miyahara N, Hizawa N, Hojo M, Hattori N, Hashimoto N, Yamasaki A, Kadowaki T, Kimura T, Miki M, Taniguchi H, Toyoshima M, Kawamura T, Matsuno O, Sato Y, Sunadome H, Nagasaki T, Oguma T, Hirai T; BEXAS study. Nomura N, et al. Respir Res. 2022 Dec 20;23(1):365. doi: 10.1186/s12931-022-02289-y. Respir Res. 2022. PMID: 36539765 Free PMC article.
Pulmonary Hypertension With Interstitial Pneumonia: Initial Treatment Effectiveness and Severity in a Japan Registry.
Tanabe N, Kumamaru H, Tamura Y, Kondoh Y, Nakayama K, Kinukawa N, Kimura T, Nishiyama O, Tsujino I, Shigeta A, Morio Y, Inoue Y, Kuraishi H, Hirata KI, Tanaka K, Kuwana M, Nagaoka T, Handa T, Sugimura K, Sakamaki F, Naito A, Taniguchi Y, Matsubara H, Hanaoka M, Inami T, Hayama N, Nishimura Y, Kimura H, Miyata H, Tatsumi K; JRPHS Group. Tanabe N, et al. Among authors: hanaoka m. JACC Asia. 2024 Mar 26;4(5):403-417. doi: 10.1016/j.jacasi.2024.01.009. eCollection 2024 May. JACC Asia. 2024. PMID: 38765657 Free PMC article.
The circadian regulation of photosynthesis.
Dodd AN, Kusakina J, Hall A, Gould PD, Hanaoka M. Dodd AN, et al. Among authors: hanaoka m. Photosynth Res. 2014 Feb;119(1-2):181-90. doi: 10.1007/s11120-013-9811-8. Epub 2013 Mar 26. Photosynth Res. 2014. PMID: 23529849 Review.
Identification of kynurenine and quinolinic acid as promising serum biomarkers for drug-induced interstitial lung diseases.
Sun Y, Saito K, Ushiki A, Abe M, Saito Y, Kashiwada T, Horimasu Y, Gemma A, Tatsumi K, Hattori N, Tsushima K, Takemoto K, Ishikawa R, Momiyama T, Matsuyama SI, Arakawa N, Akane H, Toyoda T, Ogawa K, Sato M, Takamatsu K, Mori K, Nishiya T, Izumi T, Ohno Y, Saito Y, Hanaoka M. Sun Y, et al. Among authors: hanaoka m. Respir Res. 2024 Jan 14;25(1):31. doi: 10.1186/s12931-023-02653-6. Respir Res. 2024. PMID: 38221627 Free PMC article.
EGFR-TKI rechallenge in patients with EGFR-mutated non-small-cell lung cancer who progressed after first-line osimertinib treatment: A multicenter retrospective observational study.
Araki T, Kanda S, Obara M, Agatsuma T, Kakizaki Y, Hama M, Yamamoto H, Takada M, Yamamoto M, Matsuo A, Kondo D, Komatsu M, Sonehara K, Tateishi K, Hanaoka M, Koizumi T. Araki T, et al. Among authors: hanaoka m. Respir Investig. 2024 Mar;62(2):262-268. doi: 10.1016/j.resinv.2024.01.002. Epub 2024 Jan 20. Respir Investig. 2024. PMID: 38245931 Free article.
554 results